Financial-disclosure law going into effect for drug-, device-makers

07/28/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

U.S. drug and device companies on Thursday must begin keeping records of payments made to hospitals and doctors as part of new financial disclosure rules included in the Affordable Care Act. Industry stakeholders hope the information will allay fears that these relationships adversely affect patient outcomes or result in unethical behavior.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX